Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity

Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity

US Patent 7071207 · Granted Jul 4, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel d2024
Oligosaccharide formulations of kappa opioid receptor agonists2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, an2023
Compounds for treating spinal muscular atrophy2023
Oral formulations of kappa opioid receptor agonists2023
Protein-polymer-drug conjugates2022
Markers of tissue aging and uses therefor2022
Substituted benzamides as RIPK2 inhibitors2021
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2021
Oral formulations of kappa opioid receptor agonists2021
Targeted delivery of drugs to the myometrium via polypeptides that bind to the o2021